Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radion-PDT for Oral Precancerous Lesions
NCT03279744Phase 2Completed
- Sponsor
- Pharma Power Biotec Co., Ltd.
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of Radion-pdt in oral verrucous hyperplasia (OVH), oral erythroleukoplakia, sponsored by Pharma Power Biotec Co., Ltd.. Started Sep 2017; status: completed.
02
Drugs
Radion-pdt
03
Conditions
oral verrucous hyperplasia (OVH)oral erythroleukoplakia
Beyond the preview
Go deeper on NCT03279744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03279744.